As demonstrated in Figure 1B and Table 1, elevated expression of POU5F1 predicted poor prognosis of OS in bladder cancer, breast cancer, colorectal cancer, esophageal cancer, gastric cancer, LIHC, head and neck cancer, lung cancer and other cancers, including ovarian cancer, cervical cancer, neuroblastomas, and pancreatic cancer. Here, POU5F1 is linked to urinary bladder cancer.